|
Originally published In Press as doi:10.1074/jbc.M201613200 on April 8, 2002
J. Biol. Chem., Vol. 277, Issue 24, 21529-21536, June 14, 2002
Serial Triggering of T Cell Receptors Results in Incremental
Accumulation of Signaling Intermediates*
Zipora
Borovsky,
Galit
Mishan-Eisenberg,
Einat
Yaniv, and
Jacob
Rachmilewitz
From the Goldyne Savad Institute of Gene Therapy, Hadassah
University Hospital, Jerusalem 91120, Israel
Triggering of the T cell receptor (TCR) leads to
the production of intracellular intermediates with half-life of a few
minutes. Signaling kinetics of events originating from serial TCR
triggering and its relation to antigen dose was investigated. In this
study we documented incremental accumulation of short-lived
intermediates of the extracellular signal-regulated kinase (ERK)
family, produced during successive TCR triggering. The rate and extent
of the intermediate accumulation are essentially determined by the
level of TCR engagement and are augmented by costimulation. ERK-1 and
ERK-2 exhibit different rates of accumulation following serial receptor
triggering. The data indicate that the quantitative kinetic differences
in downstream signaling pathways induce qualitatively distinct
biological outcomes. Although CD69, interleukin-2, and interferon-
(IFN- ) were primarily produced by high antigen doses that supported
high MAPK phosphorylation, maximal interleukin-5 expression is induced
by low and intermediate stimulus doses that do not support significant
accumulation of activated ERK. We further demonstrated that the rate of
phosphorylated ERK accumulation correlates with the duration of delay
between T cell stimulation and the onset of IFN- response, with
stronger stimuli giving a more rapid IFN- response. This delay might
reflect the time required for the accumulation of signaling
intermediates up to a threshold level that is necessary for activation.
Thus, the data suggest that signaling events originating from
serially triggered TCR are not simply sustained but are gradually
accumulated and are integrated in a corresponding response.
*
This work was supported by the Greensboro Community
Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Goldyne Savad Inst. of
Gene Therapy, Hadassah University Hospital, P. O. Box 12000, Jerusalem 91120, Israel. Tel.: 972-2-6777848; Fax:
972-2-6430982; E-mail: rjacob@hadassah.org.il.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. E. Schade, G. L. Schieven, R. Townsend, A. M. Jankowska, V. Susulic, R. Zhang, H. Szpurka, and J. P. Maciejewski
Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation
Blood,
February 1, 2008;
111(3):
1366 - 1377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Fierro, G. Pedraza-Alva, and Y. Rosenstein
TCR-Dependent Cell Response Is Modulated by the Timing of CD43 Engagement.
J. Immunol.,
June 15, 2006;
176(12):
7346 - 7353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Jelley-Gibbs, J. P. Dibble, S. Filipson, L. Haynes, R. A. Kemp, and S. L. Swain
Repeated stimulation of CD4 effector T cells can limit their protective function
J. Exp. Med.,
April 4, 2005;
201(7):
1101 - 1112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tsukamoto, A. Irie, and Y. Nishimura
B-Raf Contributes to Sustained Extracellular Signal-regulated Kinase Activation Associated with Interleukin-2 Production Stimulated through the T Cell Receptor
J. Biol. Chem.,
November 12, 2004;
279(46):
48457 - 48465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mishan-Eisenberg, Z. Borovsky, M. C. Weber, R. Gazit, M. L. Tykocinski, and J. Rachmilewitz
Differential Regulation of Th1/Th2 Cytokine Responses by Placental Protein 14
J. Immunol.,
November 1, 2004;
173(9):
5524 - 5530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Lea, S. J. Orr, K. Stoeber, G. H. Williams, E. W.-F. Lam, M. A. A. Ibrahim, G. J. Mufti, and N. S. B. Thomas
Commitment Point during G0->G1 That Controls Entry into the Cell Cycle
Mol. Cell. Biol.,
April 1, 2003;
23(7):
2351 - 2361.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|